clinician
often
encount
diagnost
challeng
distinguish
bacteri
viral
etiolog
febril
patient
medic
histori
physic
find
ancillari
medic
test
frequent
similar
differ
caus
agent
provid
definit
discrimin
misdiagnosi
diseas
etiolog
may
alter
trajectori
patient
care
includ
use
antibiot
fundament
individu
global
health
consequ
aid
accur
clinic
decisionmak
variou
laboratori
test
regularli
request
routin
cultur
may
aid
determin
infecti
etiolog
util
limit
lengthi
time
result
low
yield
contamin
molecular
test
expand
capabl
detect
specif
pathogen
yet
test
interpret
confound
pathogen
coinfect
signific
carriag
rate
potenti
pathogen
microorgan
molecular
test
may
contribut
diagnosi
notabl
pathogenbas
test
inher
limit
requir
sampl
infect
focu
especi
challeng
lower
respiratori
infect
fever
without
sourc
therefor
press
need
new
reliabl
rapid
test
aid
clinician
discrimin
bacteri
viral
infect
host
biomark
hold
great
promis
routin
diagnost
tool
approach
overcom
mani
previous
describ
challeng
multipl
candid
document
includ
tradit
cellular
marker
eg
white
blood
cell
count
wbc
absolut
neutrophil
count
anc
solubl
hostprotein
classic
eg
creactiv
protein
crp
procalcitonin
pct
other
eg
human
neutrophil
lipocalin
hnlngal
also
panel
host
nucleic
acid
earli
stage
develop
addit
variou
predict
model
propos
combin
sever
marker
exampl
labscor
integr
pct
crp
urinari
dipstick
result
date
wide
adopt
biomark
predict
rule
discrimin
bacteri
viral
infect
limit
one
follow
lack
rigor
clinic
valid
narrow
applic
certain
set
popul
clinic
syndrom
disput
cutoff
enough
ad
valu
beyond
standardofcar
recent
novel
hostprotein
signatur
differenti
acut
bacteri
viral
etiolog
children
adult
describ
first
diagnost
test
base
solubl
hostprotein
includ
viral
bacterialinduc
biomark
tumor
necrosi
factorrel
apoptosisinduc
ligand
trail
exhibit
induc
express
viral
infect
reduc
express
bacteri
infect
interferon
gammainduc
induc
greater
extent
viral
infect
lesser
extent
bacteri
infect
crp
exhibit
opposit
pattern
diagnost
perform
valid
two
doubleblind
studi
sensit
confid
interv
ci
specif
ci
ci
respect
former
studi
headtohead
comparison
diagnost
perform
biomark
multipl
cutoff
predict
rule
lack
patient
respiratori
infect
upper
lower
fever
without
sourc
studi
focus
two
preval
clinic
syndrom
difficult
diagnos
bacteri
viral
compar
diagnost
perform
hostprotein
signatur
commonli
appli
crp
pct
document
previous
also
headtohead
manner
multipl
cutoff
hnl
sever
predict
rule
report
candid
tool
aid
clinician
discrimin
bacteri
viral
infect
biomark
measur
perform
specimen
defin
subpopul
curios
studi
conduct
prospect
two
secondari
medic
center
israel
supplementari
materi
curios
studi
popul
compris
inpati
emerg
depart
ed
arriv
children
adult
present
divers
clinic
syndrom
spectrum
pathogen
inclus
criteria
includ
report
fever
sinc
onset
symptom
durat
symptom
day
exclus
criteria
includ
evid
acut
infect
week
preced
current
present
congenit
immun
defici
treatment
immunosuppress
immunomodulatori
agent
activ
malign
histori
human
immunodefici
viru
hepat
bc
viru
infect
curios
studi
approv
local
institut
review
board
written
inform
consent
obtain
particip
legal
guardian
applic
current
studi
includ
pediatr
adult
patient
present
one
two
clinic
syndrom
respiratori
infect
upper
lower
fever
without
sourc
sera
avail
measur
hostprotein
biomark
diagnosi
respiratori
infect
requir
sign
symptom
involv
upper
lower
respiratori
tract
includ
nose
ear
sinus
pharynx
larynx
record
electron
case
report
form
fever
without
sourc
requir
identifi
sourc
infect
record
present
care
histori
thorough
physic
examin
neg
urinalysi
data
demograph
medic
histori
physic
examin
complet
blood
count
chemistri
panel
obtain
enrol
data
also
collect
relat
addit
diagnost
test
imag
studi
perform
clinic
basi
blood
cultur
throat
cultur
serolog
test
cytomegaloviru
epsteinbarr
viru
mycoplasma
pneumonia
coxiella
burnetii
nasal
swab
obtain
microbiolog
investig
nasal
swab
store
h
transport
central
laboratori
two
multiplex
polymeras
chain
reaction
analys
conduct
detect
common
respiratori
viral
seeplex
bacteri
seeplex
pathogen
parainfluenza
viru
coronaviru
adenoviru
abcd
bocaviru
influenza
influenza
b
metapneumoviru
coronaviru
rhinoviru
abc
respiratori
syncyti
viru
b
enteroviru
streptococcu
pneumonia
haemophilu
influenza
chlamydophila
pneumonia
legionella
pneumophila
bordetella
pertussi
mycoplasma
pneumonia
singl
blood
specimen
obtain
measur
variou
biomark
upon
recruit
patient
studi
case
ed
patient
present
ed
case
inpati
within
h
admiss
venou
blood
specimen
store
h
subsequ
fraction
serum
plasma
total
leukocyt
store
hostprotein
biomark
measur
use
follow
kit
crp
use
either
roch
trail
use
meme
use
commerci
elisa
r
system
pct
use
either
elecsi
brahm
pct
kit
liaison
brahm
pct
kit
hnl
use
hnl
bact
elisa
diagnost
develop
hnl
measur
research
lab
schneider
children
medic
center
subset
specimen
suffici
volum
tabl
dilut
appli
serum
plasma
accord
manufactur
instruct
crp
trail
measur
small
subset
pct
n
n
measur
perform
part
curios
studi
major
pct
n
n
hnl
measur
conduct
frozen
serum
remnant
curios
studi
purpos
present
studi
laboratori
technician
conduct
biomark
test
blind
clinic
data
compar
method
outcom
cutoff
valu
wbc
anc
crp
pct
defin
prior
data
analysi
base
literatur
guidelin
due
lack
establish
cutoff
valu
hnl
addit
appli
previous
report
cutoff
serum
identifi
appli
addit
cutoff
current
cohort
optim
total
accuraci
serum
plasma
predict
rule
combin
biomark
differ
cutoff
defin
base
relev
literatur
prior
data
analysi
follow
predict
rule
examin
crp
mgl
pct
ngml
crp
mgl
pct
ngml
labscor
point
crp
mgl
pct
ngml
wbc
crp
mgl
pct
ngml
wbc
labscor
incorpor
pct
crp
weigh
differ
accord
level
urinari
dipstick
result
crp
mgl
point
mgl
point
mgl
point
pct
ngml
point
ngml
point
ngml
point
posit
urin
dipstick
point
hostprotein
signatur
score
rang
base
comput
integr
trail
crp
concentr
calcul
use
softwar
meme
two
cutoff
appli
accord
manufactur
instruct
gener
three
possibl
outcom
viral
infect
nonbacteri
etiolog
score
ii
equivoc
score
iii
bacteri
infect
includ
mix
bacteri
viral
coinfect
score
equivoc
outcom
nonmiss
nonerron
result
provid
diagnost
inform
ie
inconclus
patient
equivoc
outcom
exclud
analysi
hostprotein
signatur
perform
compar
method
appli
expert
panel
adjud
line
nh
health
technolog
assess
guidelin
evalu
diagnost
test
panel
compris
three
independ
experienc
clinic
practic
physician
review
discharg
clinic
laboratori
radiolog
microbiolog
data
accru
cours
patient
care
includ
pcr
analysi
nasal
swab
physician
blind
diagnos
peer
prevent
group
pressur
influenti
person
bia
panel
member
independ
assign
one
follow
diagnos
patient
bacteri
includ
mix
bacteri
viral
coinfect
ii
viral
iii
indetermin
studi
cohort
current
analysi
includ
compar
method
outcom
expert
panel
unanim
ie
three
panel
member
independ
assign
diagnosi
regard
biomark
predict
rule
studi
panel
member
provid
crp
wbc
anc
data
blind
follow
hostprotein
signatur
pct
hnl
result
predict
rule
analysi
diagnost
accuraci
across
entir
cohort
base
total
accuraci
tp
tn
p
n
sensit
tpp
specif
tnn
neg
predict
valu
npv
tn
tn
fn
posit
predict
valu
ppv
tp
tp
fp
p
n
tp
tn
fp
fn
correspond
posit
unanim
expert
panel
diagnosi
bacteri
neg
unanim
expert
panel
diagnosi
viral
true
posit
true
neg
fals
posit
fals
neg
respect
addit
subgroup
analysi
base
differ
age
group
clinic
syndrom
pathogen
microbiolog
confirm
unanim
expert
diagnosi
perform
statist
analysi
perform
use
matlab
mathwork
p
valu
calcul
follow
mean
standard
deviat
sd
test
sensit
specif
total
accuraci
fisher
exact
test
p
deem
statist
signific
p
valu
smaller
report
p
total
patient
met
inclus
criteria
present
either
respiratori
infect
upper
lower
fever
without
sourc
adequ
serum
volum
index
test
measur
assign
unanim
expert
panel
diagnos
viral
bacteri
includ
mix
bacteri
viral
fig
studi
cohort
includ
patient
respiratori
infect
patient
fever
without
sourc
tabl
supplementari
tabl
ed
common
recruit
site
median
time
symptom
onset
enrol
day
patient
assign
unanim
expert
panel
diagnos
clinic
relev
microbiolog
confirm
diagnosi
total
differ
organ
detect
supplementari
tabl
patient
initi
present
fever
without
sourc
specif
clinic
diagnosi
record
discharg
tabl
includ
bacteremia
mening
periton
lymphaden
death
crp
pct
exhibit
higher
mean
standard
deviat
level
bacteri
compar
viral
infect
fig
p
crp
mgl
vs
mgl
ngml
vs
ngml
pct
ngml
vs
ngml
hostprotein
signatur
demonstr
pronounc
differenti
bacteri
versu
viral
infect
vs
p
hostprotein
signatur
crp
pct
mean
level
mix
infect
bacteri
viral
coinfect
compar
found
pure
bacteri
infect
supplementari
figur
p
hostprotein
signatur
yield
significantli
higher
total
accuraci
differenti
viral
bacteri
infect
pct
crp
hnl
wbc
anc
p
valu
lower
tabl
assign
patient
equivoc
result
hostprotein
signatur
exhibit
compar
specif
pct
cutoff
ngml
p
yet
sensit
significantli
higher
ci
vs
ci
p
similarli
hostprotein
signatur
demonstr
compar
sensit
crp
cutoff
mgl
p
significantli
higher
specif
ci
vs
ci
p
notabl
despit
employ
cutoff
optim
accuraci
hnl
serum
specimen
protein
biomark
yield
significantli
lower
sensit
ci
vs
ci
p
specif
ci
vs
ci
p
compar
hostprotein
signatur
hostprotein
signatur
yield
significantli
improv
total
accuraci
compar
predict
rule
use
combin
pct
crp
rulein
crp
mgl
pct
ngml
ruleout
crp
mgl
pct
ngml
bacteri
infect
p
tabl
host
signatur
exhibit
compar
specif
rulein
predict
p
yet
sensit
host
signatur
significantli
higher
ci
vs
ci
p
similarli
host
signatur
demonstr
compar
sensit
ruleout
predict
p
significantli
higher
specif
ci
vs
ci
p
labscor
cutoff
yield
compar
specif
p
significantli
reduc
sensit
ci
vs
ci
p
compar
hostprotein
signatur
total
accuraci
hostprotein
signatur
significantli
superior
labscor
differenti
bacteri
viral
infect
ci
vs
p
two
predict
rule
examin
combin
crp
pct
wbc
case
total
accuraci
hostprotein
signatur
found
significantli
superior
tabl
p
model
propos
thayyil
et
al
crp
mgl
pct
ngml
wbc
yield
significantli
improv
specif
ci
vs
ci
p
significantli
lower
sensit
ci
vs
ci
p
compar
hostprotein
signatur
similarli
model
propos
olaciregui
et
al
crp
mgl
pct
ngml
wbc
yield
compar
sensit
p
significantli
lower
specif
host
signatur
ci
vs
ci
p
diagnost
perform
compar
across
subgroup
patient
present
respiratori
infect
number
respiratori
patient
unanim
expert
panel
diagnosi
bacteri
infect
number
respiratori
patient
unanim
expert
panel
diagnosi
viral
infect
similar
find
entir
cohort
hostprotein
signatur
exhibit
superior
total
accuraci
supplementari
tabl
p
sensit
specif
examin
per
pathogen
type
across
subgroup
patient
present
respiratori
infect
fig
patient
respiratori
infect
microbiolog
confirm
atyp
bacteria
includ
chlamydophila
pneumonia
mycoplasma
pneumonia
legionella
pneumophila
patient
among
viral
patient
microbiolog
confirm
rsv
influenza
b
adenoviru
patient
respect
notabl
adenoviru
infect
specif
crp
significantli
decreas
cutoff
p
wherea
hostprotein
signatur
p
compar
specif
attain
respiratori
infect
supplementari
tabl
supplementari
figur
diagnost
perform
hostprotein
signatur
robust
across
adult
children
sensit
ci
vs
ci
p
specif
ci
vs
ci
p
tabl
contrast
pct
display
significantli
decreas
sensit
adult
compar
children
cutoff
p
exhibit
reduc
specif
children
versu
adult
cutoff
signific
reduct
cutoff
pgml
p
patient
unanim
assign
viral
expert
panel
given
antibiot
indic
rate
antibiot
overus
potenti
hostprotein
signatur
reduc
antibiot
use
estim
consid
follow
ratio
number
patient
given
antibiot
assign
viral
unanim
expert
diagnosi
viral
hostprotein
signatur
n
number
patient
given
antibiot
assign
viral
unanim
expert
diagnosi
n
accord
calcul
host
signatur
potenti
reduc
unnecessari
antibiot
use
estim
perform
separ
children
adult
indic
overus
rate
respect
potenti
hostprotein
signatur
reduc
unnecessari
antibiot
use
respect
subgroup
similarli
estim
perform
separ
hospit
nonhospit
patient
indic
overus
rate
respect
potenti
hostprotein
signatur
reduc
unnecessari
antibiot
use
respect
clinic
set
studi
compar
perform
individu
combin
biomark
predict
rule
recent
develop
signatur
compris
three
patient
respiratori
infect
fever
without
sourc
observ
hostprotein
signatur
yield
significantli
superior
perform
diagnos
bacteri
versu
viral
infect
patient
compar
individu
biomark
crp
pct
wbc
anc
hnl
current
use
combin
signatur
exhibit
highest
total
accuraci
ci
sensit
ci
specif
ci
diagnost
test
show
promis
util
rulingin
rulingout
bacteri
infect
signatur
also
outperform
five
predict
rule
includ
labscor
exhibit
robust
perform
across
age
variou
pathogen
particular
even
case
adenoviru
infect
trigger
bacteriallik
respons
lead
misdiagnosi
bacteri
infect
hostprotein
signatur
maintain
perform
studi
add
valuabl
inform
previou
studi
introduc
hostprotein
signatur
headtohead
comparison
classic
eg
hnl
biomark
predict
rule
detail
analysi
perform
across
specif
pathogen
estim
potenti
new
diagnost
tool
reduc
antibiot
use
two
clinic
syndrom
challeng
clinician
manag
biomark
predict
rule
compar
studi
select
base
either
breadth
current
clinic
use
andor
potenti
applic
real
clinic
set
discrimin
bacteri
viral
respiratori
infect
fever
without
sourc
examin
nucleic
acid
panel
although
sever
research
studi
support
promis
perform
differenti
bacteri
viral
infect
current
afford
technolog
measur
multipl
rna
quantit
manner
hour
restrict
applic
nucleic
acid
biomark
pointofcar
contrast
protein
amen
afford
userfriendli
measur
within
minut
essenti
broad
applic
new
test
aid
clinician
discrimin
bacteri
viral
infect
pointofcar
platform
measur
hostprotein
signatur
min
current
develop
noteworthi
uniqu
featur
hostprotein
signatur
compar
biomark
predict
rule
examin
present
studi
inclus
viralinduc
biomark
diagnost
valu
integr
bacteri
viral
biomark
support
proofofconcept
studi
febril
emerg
depart
patient
report
improv
discrimin
microbiolog
confirm
bacteri
viral
infect
trail
pct
combin
model
compar
individu
biomark
case
signatur
like
distinct
express
dynam
three
protein
respons
bacteri
versu
viral
infect
contribut
superior
perform
key
strength
studi
applic
compar
method
base
rigor
expert
adjud
one
challeng
evalu
test
distinguish
bacteri
viral
infect
lack
gold
standard
etiolog
diagnosi
address
mani
studi
employ
microbiolog
confirm
compar
method
advantag
wellestablish
reproduc
notabl
disadvantag
restrict
cohort
small
proport
patient
like
enrich
easi
diagnos
case
inde
patient
subgroup
clinic
relev
microbiolog
confirm
unanim
expert
diagnosi
compar
full
cohort
patient
unanim
expert
diagnosi
although
employ
expert
panel
adjud
potenti
introduc
error
compar
method
fundament
advantag
encompass
greater
proport
patient
consequ
studi
cohort
close
resembl
real
clinic
set
especi
relev
respiratori
infect
fever
without
sourc
hard
diagnos
present
key
strength
breadth
index
test
compar
cutoff
defin
data
analysi
limit
studi
studi
popul
restrict
secondari
care
medic
center
much
antibiot
overus
occur
outpati
set
particularli
respiratori
infect
sinc
preval
viral
infect
typic
higher
sever
diseas
like
lower
futur
studi
signatur
diagnost
perform
physician
offic
plan
furthermor
immunocompromis
patient
oncolog
patient
exclud
studi
popul
would
benefit
greatli
test
merit
futur
studi
anoth
limit
expert
panelist
provid
crp
wbc
anc
data
introduc
potenti
incorpor
bia
evalu
diagnost
perform
test
incorpor
one
biomark
includ
hostprotein
signatur
howev
sinc
clinician
often
employ
crp
wbc
anc
part
routin
care
decid
etiolog
infect
reason
compar
method
may
impair
panelist
blind
data
notabl
despit
largest
potenti
incorpor
bia
individu
biomark
crp
wbc
anc
yield
superior
perform
conclus
studi
hostprotein
signatur
compris
trail
crp
exhibit
highest
diagnost
perform
distinguish
bacteri
viral
etiolog
patient
respiratori
infect
fever
without
sourc
need
test
highlight
find
treat
physician
prescrib
antibiot
one
third
viralinfect
patient
present
studi
cohort
hostprotein
signatur
identifi
case
viral
infect
therefor
potenti
reduc
antibiot
overus
consider
importantli
sensit
specif
potenti
may
fulfil
clinician
confid
signatur
perform
rulingin
rulingout
bacteri
infect
said
test
substitut
physician
educ
clinic
diagnosi
judici
antibiot
use
hostprotein
signatur
intend
use
conjunct
clinic
assess
laboratori
find
aid
differenti
bacteri
viral
infect
futur
health
econom
outcom
research
warrant
evalu
impact
incorpor
signatur
routin
patient
care
